FDA Requests Comments on Dietary Supplement Labeling Requirements and Recommendations

Summary

The Food and Drug Administration (FDA) is seeking public comment on proposed dietary supplement labeling requirements and recommendations under the Dietary Supplement and Nonprescription Drug Consumer Protection Act, following a submission to the Office of Management and Budget (OMB) for review and clearance.